UNSPSC 51123200: Antiarrythmic amines

This classification denotes compounds derived from ammonia by substituting organic radicals for the hydrogens, substances called amines, that prevent or treat irregular heartbeat, disturbances of normal rhythmic heart beating, or normal operation of myocardial contraction, thus the term ANTIARRYTHMIC AMINES.

UNSPSC 51123200 Antiarrhythmic amines, a Class code, encompasses specific injectable cardiac medications that state and local emergency services and health agencies procure for Advanced Life Support protocols and pharmacy benefit programs. State and local governments acquire these products — including labetalol, epinephrine, adenosine, and diltiazem formulations — through direct pharmaceutical procurement to stock emergency response vehicles, clinical facilities, and state health benefit programs. Issuing bodies span city fire departments, county emergency services, state health and human services commissions, and multistate cooperative purchasing alliances. The Tampa Fire Rescue acquisition and the Minnesota Multistate Cooperative Purchasing Alliance (MMCAP) RFP represent the dominant issuing-body patterns: individual municipalities and state-coordinated cooperative vehicles that aggregate demand across member jurisdictions including participating local and state facilities.

Recent activity concentrates in Florida and the Upper Midwest. The City of Tampa's Purchasing Department issued an IFB (Bid No. 26P00188) due April 8, 2026, for Advanced Life Support Medications totaling approximately $40,000 for Tampa Fire Rescue in Hillsborough County, requiring 370 units of Labetalol HCI 100mg vials, 1,810 units of Epinephrine 1:10,000 injections, 330 units of Adenosine 6mg vials, and 1,020 units of Diltiazem 25mg vials with nine-month minimum expiration dating and firm delivery within ten calendar days. The Minnesota Department of Administration's Office of State Procurement, administering MMCAP, issued an RFP (S1070000015802) due March 26, 2026, for generic multi-source pharmaceuticals and OTC products distributed through AmerisourceBergen, Cardinal Health, and Morris & Dickson across participating state and local government facilities in Minnesota and Oregon, with awards effective July 1, 2026. The Texas Health and Human Services Commission issued an exploratory RFI (HHS0017013) in April 2026 regarding direct-to-manufacturer prescription fulfillment capability, signaling early-stage state procurement interest in alternative distribution models for pharmacy benefit programs outside traditional PBM and GPO channels.